Skip to content
Nonprofiteer
← INTERNATIONAL SOCIETY FOR PHARMACEUTICAL ENGINEERING INC

Form 990 for tax year 2022

Filed by INTERNATIONAL SOCIETY FOR PHARMACEUTICAL ENGINEERING INC.

Totals

Total revenue
$15,080,135
Total expenses
$13,532,053
Contributions and grants received
$0
Grants paid
$85,000
Program service revenue
$13,269,545
Investment income
$227,582
Other revenue
$1,583,008
Total assets, end of year
$16,259,417
Total liabilities, end of year
$8,703,022
Net assets or fund balances, end of year
$7,556,395
Program services expenses (Part IX)
$0
Management and general expenses
$0
Fundraising expenses
$0
Program service expenses (Part III)
$12,111,790

Program services were 0.0% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 2a · Program service revenue: PROFESSIONAL DEVELOPMENT

    total $8,584,973 · related or exempt $8,584,973

  • 2b · Program service revenue: MEMBERSHIP DUES

    total $3,100,697 · related or exempt $3,100,697

  • 2c · Program service revenue: ADVERTISING FEES

    total $1,583,875 · related or exempt $648,816 · unrelated business $935,059

  • 3 · Investment income

    total $158,487 · excluded $158,487

  • 7a · Gross sales of assets other than inventory

    securities $1,670,779 · other assets $34,246

  • 7b · Less cost or other basis and sales expenses

    securities $1,635,930

  • 7c · Gain or loss

    securities $34,849 · other assets $34,246

  • 7d · Net gain or loss

    total $69,095 · related or exempt $34,849 · excluded $34,246

  • 10a · Gross sales of inventory

    $3,129,744

  • 10b · Cost of goods sold

    $1,592,682

  • 10c · Net income from sales of inventory

    total $1,537,062 · related or exempt $1,537,062

  • 11a · Other revenue: MISCELLANEOUS

    total $45,946 · related or exempt $45,946

  • 11e · Other revenue, total

    $45,946

Functional expenses

Part IX, the statement of functional expenses.

  • 1 · Grants to domestic organizations and governments

    total $85,000

  • 6 · Compensation of disqualified persons

    total $579,801

  • 7 · Other salaries and wages

    total $3,191,654

  • 8 · Pension plan contributions

    total $175,207

  • 9 · Other employee benefits

    total $290,384

  • 10 · Payroll taxes

    total $258,127

  • 11a · Fees: management

    total $121,061

  • 11b · Fees: legal

    total $259,503

  • 11c · Fees: accounting

    total $67,945

  • 11g · Fees: other

    total $237,724

  • 12 · Advertising and promotion

    total $2,598,294

  • 13 · Office expenses

    total $214,241

  • 16 · Occupancy

    total $374,928

  • 17 · Travel

    total $242,646

  • 19 · Conferences, conventions and meetings

    total $108,062

  • 22 · Depreciation, depletion and amortization

    total $112,923

  • 23 · Insurance

    total $65,270

  • 24a · Other expenses: SITE COSTS

    total $1,812,988

  • 24b · Other expenses: READERSHIP COSTS

    total $535,099

  • 24c · Other expenses: ELECTRONIC LICENSES

    total $462,451

  • 24d · Other expenses: MEMBERSHIP DIRECTORY

    total $385,729

  • 24e · All other expenses

    total $1,353,016

Balance sheet

Part X, book values.

  • 1 · Cash, non-interest-bearing

    beginning of year $3,284,235 · end of year $5,097,740

  • 2 · Savings and temporary cash investments

    beginning of year $189,588 · end of year $128,600

  • 4 · Accounts receivable

    beginning of year $767,941 · end of year $1,565,331

  • 8 · Inventories for sale or use

    beginning of year $31,457 · end of year $27,944

  • 9 · Prepaid expenses and deferred charges

    beginning of year $248,148 · end of year $441,016

  • 10a · Land, buildings and equipment: cost or other basis

    $2,227,686

  • 10b · Land, buildings and equipment: accumulated depreciation

    $2,054,635

  • 10c · Land, buildings and equipment, net

    beginning of year $380,877 · end of year $173,051

  • 11 · Investments: publicly traded securities

    beginning of year $6,780,151 · end of year $6,163,438

  • 15 · Other assets

    beginning of year $99,040 · end of year $2,662,297

  • 17 · Accounts payable and accrued expenses

    beginning of year $1,532,946 · end of year $2,665,561

  • 19 · Deferred revenue

    beginning of year $3,249,779 · end of year $3,427,772

  • 25 · Other liabilities

    end of year $2,609,689

  • 27 · Net assets without donor restrictions

    beginning of year $6,998,712 · end of year $7,556,395

Mission and programs · 2022

Mission

TO LEAD SCIENTIFIC, TECHNICAL AND REGULATORY ADVANCEMENT THROUGHOUT THE ENTIRE PHARMACEUTICAL LIFECYCLE.

  • PROFESSIONAL DEVELOPMENT CONSISTS PRIMARILY OF CONFERENCES AND TRAINING COURSES TO KEEP INDUSTRY PROFESSIONALS INFORMED OF THE LATEST TECHNOLOGICAL AND REGULATORY TRENDS AND TO HELP THE PHARMACEUTICAL MANUFACTURING PROFESSION AS A WHOLE TO ENSURE THE SAFETY OF THE WORLD'S SUPPLY OF MEDICINES.

    Expenses $6,607,043 · Revenue $8,584,973

  • MEMBER COMMUNICATION SERVICES INCLUDE SUBSCRIPTIONS AND ARTICLE REPRINTS PROVIDING THE MOST UP-TO-DATE INFORMATION ON THE LATEST TECHNOLOGICAL AND REGULATORY TRENDS IN THE PHARMACEUTICAL MANUFACTURING INDUSTRY. MEMBERS RECEIVE A SUBSCRIPTION TO THE PHARMACEUTICAL ENGINEERING MAGAZINE, WHICH PROVIDES A COMPREHENSIVE SELECTION OF PRACTICAL APPLICATION ARTICLES AND INFORMATION OF IMPORTANCE TO THE INDUSTRY AND MEMBERSHIP.

    Expenses $3,167,691 · Revenue $3,100,697

  • GUIDANCE DOCUMENTS INCLUDE THE DEVELOPMENT AND PUBLISHING OF GUIDANCE INFORMATION INCLUDING BEST PRACTICES AND INNOVATIVE AND EFFECTIVE SOLUTIONS TO INDUSTRY CHALLENGES.

    Expenses $2,337,056 · Revenue $1,583,875

As filed on the 2022 return.

Listed in Part VII

  • Mr Thomas B Hartman

    PRESIDENT/CE

    Total calculated
    $367,584
    From this org
    $343,672
    From related orgs
    $0
    Other
    $23,912
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $267,172
    Bonus
    $76,500
    Other
    not reported
    Deferred
    $23,380
    Nontaxable benefits
    $532
    Filer's total
    $367,584
  • Mr Mark Hernick

    COO

    Total calculated
    $266,550
    From this org
    $236,129
    From related orgs
    $0
    Other
    $30,421
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $184,575
    Bonus
    $51,554
    Other
    not reported
    Deferred
    $24,924
    Nontaxable benefits
    $5,497
    Filer's total
    $266,550
  • Mr Bradley Ettinger

    VP, SALES &

    Total calculated
    $245,878
    From this org
    $215,909
    From related orgs
    $0
    Other
    $29,969
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $175,094
    Bonus
    $40,815
    Other
    not reported
    Deferred
    $24,924
    Nontaxable benefits
    $5,045
    Filer's total
    $245,878
  • Ms Jessica Bleess

    AVP, CONF &

    Total calculated
    $168,684
    From this org
    $146,797
    From related orgs
    $0
    Other
    $21,887
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $128,779
    Bonus
    $18,018
    Other
    not reported
    Deferred
    not reported
    Nontaxable benefits
    $21,887
    Filer's total
    $168,684
  • Mr Thomas Zimmer PhD

    VP EUROPEAN

    Total calculated
    $152,551
    From this org
    $152,551
    From related orgs
    $0
    Other
    $0
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $152,551
    Bonus
    not reported
    Other
    not reported
    Deferred
    not reported
    Nontaxable benefits
    not reported
    Filer's total
    $152,551
  • Ms Vivianne Arencibia

    SECRETARY

    Total calculated
    $0
    Hours/week
    1
  • Mr Scott Billman

    VICE CHAIR

    Total calculated
    $0
    Hours/week
    1
  • Mr David Churchward

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • Ms Ylva Ek

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • Mr Norman Goldschmidt

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • Mr Michael Martin

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • Ms Sarah Miksinski

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • Ms Teresa Minero

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • Mr Jeff Biskup PE

    TREASURER

    Total calculated
    $0
    Hours/week
    1
  • Mr Georg Singewald PhD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • Mr Tim Watson PhD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • Ms Nina S Cauchon PhD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • Mr Michael L Rutherford

    CHAIR

    Total calculated
    $0
    Hours/week
    1
  • Mshirofumi Suzuki

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • Mr Jorg Zimmermann

    PAST CHAIR

    Total calculated
    $0
    Hours/week
    1

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.

Schedule J

Answered yes

  • 3 · Independent compensation consultant
  • 3 · Written employment contract
  • 3 · Compensation survey or study
  • 3 · Approval by the board or compensation committee

Answered no

  • 4a · Severance or change-of-control payment
  • 4b · Supplemental nonqualified retirement plan
  • 4c · Equity-based compensation arrangement

Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.

Grants on this return

Activities outside the United States

From Schedule F of this return, as filed.

Offices (line 3c)
—
Employees, agents and contractors (line 3c)
2
Expenditures and investments (line 3c)
$1,031,840

At most 25 lines of each part are listed here. Schedule F names no grantee, so each line is a region and its money.

Activities by region (Part I)

Region Offices Employees Activity Specific services Expenditures
EUROPE — 1 PROGRAM SERVICE PROF DEV & MEMB SERV $1,027,905
EAST ASIA AND THE PACIFIC — 1 PROGRAM SERVICE PROF DEV & MEMB SERV $3,935
Transferred property to a foreign corporation during the year (line 1)
No
Had an interest in a foreign trust (line 2)
No
Owned an interest in a foreign corporation (line 3)
Yes
Was a shareholder of a passive foreign investment company or qualified electing fund (line 4)
No
Owned an interest in a foreign partnership (line 5)
No
Had operations in or related to a boycotting country (line 6)
No

Provenance

Return type
form_990
Tax year
2022
Filed
17 November 2023
IRS schema version
2022v5.0
Source object
202333219349300543

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.